在心血管疾病中使用草药 - - 综述
Arshdeep Kaur1, Ranjeet Kumar1
1Department of Pharmacy Practice, ISF College of Pharmacy, Moga, (Punjab), India.
Current cardiology reviews
|September 4, 2024
概括
心血管疾病 (CVD) 导致全球30%的死亡. 本综述探讨了药用植物中的植物化学物质如何帮助管理心血管疾病风险并预防疾病进展.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 民族植物学 民族植物学
背景情况:
- 心血管疾病 (CVD) 是全球死亡的主要原因,占所有死亡的30%.
- 世卫组织的数据显示,每年有1790万例死亡,预计到2030年将增加到2220万例,女性受影响不成比例.
- 植物化学物质,植物衍生化合物,越来越多地被用作预防和治疗心血管疾病的补充或替代治疗方法.
研究的目的:
- 审查各种草药治疗心血管疾病的治疗应用.
- 阐明这些草药治疗的作用机制,活性植物化学成分和潜在的副作用.
- 突出植物化学品在减轻心血管风险中的作用.
主要方法:
- 对用于心血管疾病管理的药用植物及其植物化学物质的文献综述.
- 对治疗心血管疾病的草药疗法的疗效和安全性的科学数据的分析.
- 确定关键的植物化学化合物及其药理作用.
主要成果:
- 植物化学物质在降低心血管风险方面表现出有效性,包括降低血中胆固醇,控制肥胖和2型糖尿病,控制氧化应激和炎症,并抑制血小板聚合.
- 某些特定的药用植物,如人参,金科宝罗巴,Ganoderma lucidum,Gynostemma pentaphyllum和Amaranthus viridis,因其治疗心血管疾病的特性而闻名.
- 关键的活性植物化学物质包括植物固醇,黄类,多类,硫化合物和类.
结论:
- 草药及其植物化学物质为预防和治疗心血管疾病提供了有希望的途径.
- 进一步的研究对于充分了解植物性心血管疾病治疗中涉及的机制和特定植物化学物质至关重要.
- 整合基于证据的草药治疗可以提高心血管健康结果.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
01:22Heart Failure Drugs: β-Blockers
2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
01:16Antianginal Drugs: Nitrates and β-Blockers
1.9K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
01:30Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741